Janella Funes
Nessuna posizione attualmente
Profilo
Ms. Janella Funes is Chief of Staff at NantWorks LLC.
Ms. Funes was previously employed as a Director-Program Management by Abraxis BioScience, Inc., a Manager-Program & Operations by MannKind Corp., Business Development Associate by Allecure Corp., and Development Associate by Keck Graduate Institute of Applied Life Sciences.
She received her undergraduate degree from Claremont McKenna College and a graduate degree from Claremont Graduate University.
Precedenti posizioni note di Janella Funes
| Società | Posizione | Fine |
|---|---|---|
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 01/04/2011 |
| MANNKIND CORPORATION | Corporate Officer/Principal | 01/01/2005 |
Allecure Corp.
 Allecure Corp. Pharmaceuticals: MajorHealth Technology Allecure Corp. developed and commercialized therapeutic products. The company was headquartered in Valencia, CA. | Corporate Officer/Principal | 01/01/2003 |
| Keck Graduate Institute of Applied Life Sciences | Corporate Officer/Principal | 01/05/2000 |
NantWorks LLC
 NantWorks LLC Information Technology ServicesTechnology Services NantWorks LLC develops technology based semiconductor and advanced networks for healthcare improvements. Its solution is for life threatening diseases such as cancer, infectious diseases and Alzheimer’s. The company was founded by Patrick Soon-Shiong in September 2011 and is headquartered in Culver City, CA. | Ufficiale delle Risorse Umane | - |
Formazione di Janella Funes
| Claremont McKenna College | Undergraduate Degree |
| Claremont Graduate University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| Aziende private | 3 |
|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Allecure Corp.
Allecure Corp. Pharmaceuticals: MajorHealth Technology Allecure Corp. developed and commercialized therapeutic products. The company was headquartered in Valencia, CA. | Health Technology |
NantWorks LLC
NantWorks LLC Information Technology ServicesTechnology Services NantWorks LLC develops technology based semiconductor and advanced networks for healthcare improvements. Its solution is for life threatening diseases such as cancer, infectious diseases and Alzheimer’s. The company was founded by Patrick Soon-Shiong in September 2011 and is headquartered in Culver City, CA. | Technology Services |
- Borsa valori
- Insiders
- Janella Funes
